Associated Papers
Comprehensive pharmacogenomics profiling of the Serbian population.
Jelovac M et al.
Frontiers in Pharmacology, 2025
40166472 (PubMed )
Supplement: DataSheet1.xlsx › 4._CES_WES
Pharmacogenetic analysis of structural variation in the 1000 genomes project using whole genome sequences.
Sherman CA et al.
Scientific Reports, 2024
APF2: an improved ensemble method for pharmacogenomic variant effect prediction.
Zhou Y et al.
The Pharmacogenomics Journal, 2024
38802404 (PubMed )
Supplement: 41397_2024_338_MOESM2_ESM.xlsx › Sheet1
An optimized prediction framework to assess the functional impact of pharmacogenetic variants.
Zhou Y et al.
The Pharmacogenomics Journal, 2019
30206299 (PubMed )
Supplement: 41397_2018_44_MOESM5_ESM.xlsx › Sheet1
Biochemical analysis of recombinant CYP4A11 allelic variant enzymes: W126R, K276T and S353G.
Han S et al.
Drug Metabolism and Pharmacokinetics, 2016
Functional characterization of 10 CYP4A11 allelic variants to evaluate the effect of genotype on arachidonic acid ω-hydroxylation.
Saito T et al.
Drug Metabolism and Pharmacokinetics, 2015
Expression of CYP2A6, CYP2D6 and CYP4A11 Polymorphisms in COS7 Mammalian Cell Line.
Lee HJ et al.
Toxicological Research, 2011
Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population.
Ding H et al.
Pharmacogenetics and Genomics, 2010
Select a paper to view details